Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 470, pseudogene (RN7SL470P)

Target
RN7SL470P
Molecular classification
Pseudogene, Noncoding RNA (derived from 7SL RNA)
01

Overview

RN7SL470P is a human pseudogene derived from the 7SL RNA gene, which originally codes for the RNA component of the signal recognition particle (SRP)[1][3][4][7]. The authentic 7SL RNA is an essential noncoding RNA that facilitates the translation and targeting of secretory and membrane proteins within the cell by being part of the SRP ribonucleoprotein complex[5][9]. Pseudogenes like RN7SL470P are typically truncated, non-functional copies resulting from reverse transcription and integration events. Most 7SL RNA pseudogenes are not expressed at the protein or RNA level and do not participate in known biological processes or diseases[3][7]. However, some pseudogenes in general—though not specifically RN7SL470P—have been implicated in gene regulation through RNA interference or microRNA buffering mechanisms[6]. RN7SL470P does not belong to any major target class for therapeutics (e.g., receptor, enzyme) and does not have a recognized physiological, pathological, or pharmacological role. Its presence is mainly a genomic relic, a byproduct of evolutionary events, and it serves primarily in research contexts as a marker of pseudogene diversity within the human genome[3][4][7].

Other names
RN7SL470PRNA, 7SL, cytoplasmic 470, pseudogene
02

Mechanism of action

None known

03

Biological functions

no confirmed biological function for this specific pseudogene
04

Disease associations

no confirmed disease association
05

Safety considerations

None known
06

Interacting drugs

None known
07

Biomarkers

None known

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 470, pseudogene (RN7SL470P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 470, pseudogene (RN7SL470P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call